Publisher： Adis International
ISSN： 1173-8324
Source： Inpharma, Vol.1, Iss.1374, 2003-01, pp. : 4-4
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Basiliximab confers significant clinical benefit for marginal cost
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 399, 2003-01 ,pp. :
Access to resources
Recommend
Salmeterol/fluticasone propionate confers benefit for minimal cost in asthma
Inpharma, Vol. 1, Iss. 1359, 2002-01 ,pp. :
Salmeterol/fluticasone propionate confers benefit for minimal cost in asthma
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 384, 2002-01 ,pp. :
Intracranial stents − clinical benefit offset by significant costs
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 622, 2011-01 ,pp. :
Sertraline: an assessment of clinical benefit and cost in the UK
European Neuropsychopharmacology, Vol. 5, Iss. 3, 1995-09 ,pp. :